Mark R. Litzow

Active 1993–2025

313
Papers
41,883
Citations
110
h-index
291
i10-index

Citations

Citations per year for Mark R. Litzow1976: 1 citations1986: 1 citations1995: 4 citations1996: 4 citations1997: 2 citations1999: 5 citations2000: 12 citations2001: 23 citations2002: 22 citations2003: 54 citations2004: 60 citations2005: 80 citations2006: 81 citations2007: 128 citations2008: 159 citations2009: 166 citations2010: 243 citations2011: 210 citations2012: 265 citations2013: 285 citations2014: 267 citations2015: 305 citations2016: 335 citations2017: 301 citations2018: 291 citations2019: 1,146 citations2020: 1,322 citations2021: 1,344 citations2022: 1,155 citations2023: 935 citations2024: 1,731 citations2025: 829 citations2026: 19 citations1977–1985: no citations, so these years are not shown1987–1994: no citations, so these years are not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,754 citing papers, 30.1% of this breakdownGermany: 1,113 citing papers, 7.1% of this breakdownChina: 1,107 citing papers, 7% of this breakdownItaly: 979 citing papers, 6.2% of this breakdownUnited Kingdom: 907 citing papers, 5.8% of this breakdownFrance: 828 citing papers, 5.2% of this breakdownSpain: 541 citing papers, 3.4% of this breakdownCanada: 505 citing papers, 3.2% of this breakdownNetherlands: 443 citing papers, 2.8% of this breakdownAustralia: 397 citing papers, 2.5% of this breakdownJapan: 355 citing papers, 2.3% of this breakdownSwitzerland: 313 citing papers, 2% of this breakdown
0%30.1%Other 22.4%

Fields

  • Medicine80.6%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Immunology and Microbiology4.1%
  • Computer Science0.2%
  • Economics, Econometrics and Finance0.2%
  • Engineering0.2%
  • Other1%

Topics

  • Acute Myeloid Leukemia Research11.1%
  • Acute Lymphoblastic Leukemia research6.8%
  • Hematopoietic Stem Cell Transplantation6.4%
  • Chronic Myeloid Leukemia Treatments5.4%
  • CAR-T cell therapy research4.4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.1%
  • Other61.8%

Coauthors

All papers

Open in search
  1. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 960

  2. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 1,259

  3. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John C. Byrd - New England Journal of Medicine 2018 cited by 952

  4. Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 187

  5. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly W. Maloney, Alessandro Rambaldi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Janis Racevskis, Yanming Zhang, Ravi Bhatia, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Wendy Stock, Steven M. Kornblau, Hagop M. Kantarjian, Marina Konopleva, Williams E. Evans, Sima Jeha, Ching‐Hon Pui, Jun J. Yang, Elisabeth Paietta, James R. Downing, Mary V. Relling, Jinghui Zhang, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan - Nature Genetics 2019 cited by 617

  6. Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 738

  7. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 237

  8. Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross L. Levine - New England Journal of Medicine 2012 cited by 1,948

  9. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen, on behalf of the BMT-CTN 1506/MORPHO Study Investigators, Ed Agura, Jessica K. Altman, Achiles Anagnostopoulos, Sarah Anand, Andrew Artz, Walter E. Aulitzky, Sophia Balderman, Karen K. Ballen, Michael W. Becker, Yves Béguin, Leanne Berkahn, Zwi Berneman, Vijaya Raj Bhatt, Ian Bilmon, Francesca Bonifazi, Adrienne Briggs, Benedetto Bruno, Claudio G. Brunstein, Michael Byrne, Jenny Byrne, Mónica Cabrero, Roberto Cairoli, George Carrum, Jan Černý, Yi‐Bin Chen, June‐Won Cheong, Fabio Ciceri, Mercedes Colorado, Rachel J. Cook, Daniel R. Couriel, Charles Craddock, Lloyd E. Damon, Abhinav Deol, Yohan Desbrosses, Steve Devine, Carmela Di Grazia, Antonio Di Stasi, Ajoy Dias, Kathy Dorritie, James Essell, Tetsuya Eto, Sherif S. Farag, Édouard Forcade, Olga Frankfurt, Shin‐ichiro Fujiwara, Takahiro Fukuda, Kentaro Fukushima, Sabine Fürst, Tatsunori Goto, Aric C. Hall, Shunsuke Hatta, Yosr Hicheri, Mitchell E. Horwitz, Hsin‐An Hou, Jonathan How, Dianna S. Howard, Wei‐Hsun Hsu, Anne Huynh, David Irvine, Takayuki Ishikawa and 109 more - Journal of Clinical Oncology 2024 cited by 185

  10. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2019 cited by 471

  11. Palliative Care for Patients With Cancer: ASCO Guideline Update

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2024 cited by 279

  12. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle A. Elliott, Anjali S. Advani, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Elad Sharon, Richard F. Little, Harry P. Erba, Richard M. Stone, Selina M. Luger, Charles G. Mullighan, Martin S. Tallman - New England Journal of Medicine 2024 cited by 215

  13. DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA 2023 cited by 144

  14. Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jun Yin, Steven M. Kornblau, Stephen P. Hunger, Mignon L. Loh, Ching‐Hon Pui, Wenjian Yang, Kristine R. Crews, Kathryn G. Roberts, Jun J. Yang, Mary V. Relling, William E. Evans, Wendy Stock, Elisabeth Paietta, Adolfo A. Ferrando, Jinghui Zhang, Wolfgang Kern, Torsten Haferlach, Gang Wu, John E. Dick, Jeffery M. Klco, Claudia Haferlach, Charles G. Mullighan - Cancer Discovery 2021 cited by 188

  15. Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 907

  16. A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

    Authors: , , , , , , , , - Cell Research 2018 cited by 256

  17. Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deborah A. Freedman-Cass, Mallory Campbell - Journal of the National Comprehensive Cancer Network 2021 cited by 241

  18. Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Hematology 2023 cited by 75

  19. High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wendy Stock, Stephen Kornblau, Hagop M. Kantarjian, Marina Konopleva, Elisabeth Paietta, Cheryl L. Willman, Charles G. Mullighan - Journal of Clinical Oncology 2017 cited by 449

  20. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 168

  21. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Easton, Jinghui Zhang, Junmin Peng, Hongbo Chi, Stanley Pounds, Mary V. Relling, Hiroto Inaba, Xiaofan Zhu, Steven M. Kornblau, Ching‐Hon Pui, Marina Konopleva, David T. Teachey, Charles G. Mullighan, Kimberly Stegmaier, William E. Evans, Jiyang Yu, Jun J. Yang - Nature Cancer 2021 cited by 157

  22. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

    Authors: , , , , , , , , , , , , , - Blood 2006 cited by 843

  23. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 488

  24. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Vietz, Eric A. Severson, Molly Miller, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy F. Chen, Mona Stefanos, Brian Druker, John C. Byrd - Nature Medicine 2020 cited by 192